New Delhi, July 11 -- The National Pharmaceutical Pricing Authority (NPPA) capped the retail price of 39 medicines, including those for hypertension, diabetes and heart disease.

A notice by the Ministry of Chemicals and Fertilizers issued on July 8 stated the National Pharmaceutical Pricing Authority fixed the retail price of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.

The formulations cover a wide range of medicines, including those used to treat hypertension, diabetes, HIV, heart disease and eye infections, with the aim of making them more affordable for patients.

The price of Amlodipine Bisoprolol Telmisartan Tablets, used for the treatment of hypertension (high blood pressure), was fixed at Rs.14.7...